Main Article Content


In this study, adult Indian people with diabetes (PWD) were examined in connection to their knowledge of the condition, glycemic control, and self-care practices. Diabetes mellitus (DM) is a metabolic disease, involving inappropriately elevated blood glucose levels. This is a serious medical problem that has a significant impact on global mortality, morbidity, and health-system costs. Patients with chronic diseases like Diabetes Mellitus can enhance their self-care routines by receiving health education. Chi-square and correlation analysis were used to investigate how knowledge of a condition related to self-care and glycemic control. Majority of the sample was >45–60 years old (51.1%), suffering from type 2 diabetes mellitus for<10 years (54%) and had poor glycemic control (HbA1C≥7%; n=102 participants). Diabetes patients with good glycemic control (HbA1c7) had a similar diabetes knowledge score (DKQ sum-scale score 12; IQR 10.75-14) as those with poor glycemic control (DKQ sum-scale score 12; IQR 10-15). Significantly (p<0.05) higher DKQ sum-scale scores were obtained by study participants aged 45-60 years (13; IQR 10-15), participants who had postgraduate level education (15; IQR 13-17), and participants having a family history of diabetes (13; IQR 10.25-15). Glycated haemoglobin levels and disease knowledge do not significantly correlate: however, disease knowledge is significantly correlated with PWDs' self-care practices. These findings will aid in the development of patient-specific diabetes education programmes that will increase the likelihood that diabetes patients will adopt appropriate self-care practices which ultimately aids in achieving target glycemic control.


Knowledge Glycated Hemoglobin Self-Management Glycemic Control HbA1c

Article Details

How to Cite
Viswa Srujani Kanagala, Rachamalla Naga Velangani Sai Sree, Noonsavath Prameela Devi Bai, Putti Preethi, & Sai Ashok Kumar Domasani. (2023). A Study on Impact of Diabetes Knowledge on Glycemic Control and Self-Care Activities Among Adults with Type II Diabetes Mellitus. International Journal of Pharmaceutical Research and Life Sciences, 11(1), 5-15.